Cinqair (reslizumab)

pCPA File Number: 20781

Negotiation Status:

Concluded without agreement

Indication(s):

Eosinophilic Asthma

Sponsor/Manufacturer:

Teva Canada Ltd.

CDA-AMC Project Number:

SR0495-000

pCPA Engagement Letter Issued:

2017-07-24

Negotiation Process Concluded:

2018-11-15